Results 91 to 100 of about 303,882 (203)

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Association Between Thyroid Nodules and Thyroid Cancer Risk in Graves’ Disease: A Surgical Cohort from an Iodine-deficient Region

Haseki Tıp Bülteni
Aim: The clinical relevance of thyroid nodules in Graves’ disease (GD) remains controversial, particularly in iodine-deficient regions where both nodularity and thyroid cancer are more prevalent.
Tugba Matlim Ozel, Mine Yilmaz, Sezer Akbulut, Aykut Celik, Gorkem Yildiz, Nilsen Yildirim Erdogan, Serkan Sari   +6 more
doaj   +1 more source

Association of CTLA4 and TNF gene polymorphisms with endocrine ophthalmopathy in ethnic Russian patients with Graves’ disease

Терапевтический архив, 2015
Aim. To analyze the associations of the rs3087243 CTLA4 polymorphism and the rs1800629 TNF polymorphism with endocrine ophthalmopathy (EOP) in ethnic Russian patients with Graves’ disease (GD). Subjects and methods.
N S Martirosian, A M Burdennyi, L V Trukhina, O G Panteleeva, S V Saakyan, N A Petunina, V V Nosikov   +6 more
doaj  

Case Report: A Patient with Severe Graves’ Ophthalmopathy and Follicular Carcinoma

Endocrinology Research and Practice, 2007
Graves’ disease is the most common form of thyrotoxicosis and may occur at any age, more commonly in females. It is currently viewed as an autoimmune disease of unknown cause.
Oya Topaloğlu, Bekir Çakır, Ahmet Dirikoç, Cevdet Aydın, Tuba Ağaç, Ayşegül Koçak, Ahmet Kutluhan, Raci Aydın   +7 more
doaj   +2 more sources

Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment

, 2008
Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, School of Medicine, Sapporo, JapanPurpose: To investigate whether serum levels of soluble Fas (sFas) and interleukin-6 (IL-6) could ...
Masato Hashimoto, Hiroshi Ohguro, Kimihito Maeda, Yuichiro Ohara   +3 more
core  

[Classification of endocrine ophthalmopathy].

Problemy endokrinologii
Based on the analysis of the classifications of endocrine ophthalmopathy (EOP), described in the literature and their many years' own observations of patients with this condition, the authors propose their classification. EOP is divided into 3 forms, 2 of which may be characterized by the compensation of a pathological process and by the stages of its ...
A F, Brovkina, A S, Stoyukhlna
openaire   +1 more source

Management of endocrine ophthalmopathy. [PDF]

BMJ, 1968
openaire   +3 more sources

Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

, 2010
Hooshang Lahooti, Kishan R Parmar, Jack R WallThe Department of Medicine, University of Sydney, Nepean Clinical School, Penrith, NSW, AustraliaAbstract: Thyroid-associated ophthalmopathy (TAO), or thyroid eye disease, is a complex inflammatory disorder ...
Hooshang Lahooti, Kishan R Parmar, Jack R Wall   +2 more
core  

[The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice]. [PDF]

Probl Endokrinol (Mosk)
Sviridenko NY, Ananicheva EV, Gershevich VM, Grusha YO, Chepilev KA, Surov AV, Yurgel VV, Shchukin KS, Bessmertnaya EG, Bilevich OA.   +9 more
europepmc   +1 more source

[The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].

, 1992
The most frequently used medical treatment of Graves' ophthalmopathy is the combination of orbital irradiation and systemic corticosteroid. In this study the effectiveness of "high dose intravenous immunoglobulin" (IVIG) in Graves' ophthalmopathy ...
Alberti B, Baschieri L., ANTONELLI, ALESSANDRO, Lepri A, Saracino A, Laddaga M, Melosi A, Cartei F   +7 more
core